Agent |
Dosage |
Contraindications | |
Acutea |
Long term | ||
Adenosine (IV) |
6 mg in rapid IV injection followed by 12 or 18 mg after 1-2 min when necessary |
– |
Sinus node dysfunction, second-degree or third-degree AV block,b asthma. Use with caution in AF or AFL with suspected accessory pathway, prolonged QT, severe HF, or hypotension |
Amiodarone (IV, PO) |
5 mg/kg (most often 300 mg) IV over 15-30 min (infusions over 60-120 min are safer) followed by 900 mg/24 h (infusion); max, 1200 mg/d (sometimes up to 2000 mg/d) |
Loading dose: 200 mg (in selected cases 400 mg) tid for 7-14 days followed by 200 mg bid for 7-14 days Maintenance dose: usually 200 mg/d, in selected cases 100 or 300-400 mg/d |
Sinus node dysfunction, second-degree or third-degree AV block,b prolonged QT, drug hypersensitivity, thyrotoxicosis, liver disease, pregnancy, breastfeeding |
Digoxin (IV, PO) |
0.25 mg IV every 2 h; max total dose, 1.5 mg |
0.125-0.375 mg/d |
Bradycardia,b second-degree or third-degree AV block,b sick sinus syndrome,b carotid sinus syndrome, hypertrophic cardiomyopathy with outflow tract obstruction, preexcitation syndromes, hypokalemia, hypercalcemia, planned electrical cardioversion |
Diltiazem (PO) |
– |
90-240 mg/d |
HF, second-degree or third-degree AV blockb |
Dronedarone (PO) |
– |
400 mg bid |
Second-degree or third-degree AV block,b sick sinus syndrome,b HF or asymptomatic LV dysfunction, permanent AF |
Flecainide (IV, PO) |
2 mg/kg IV bolus (max, 150 mg) PO: 300 mg (“pill in the pocket” for acute AF) |
50-150 mg PO bid |
Structural heart disease (in particular heart failure), CAD, sinus node dysfunction, second-degree or third-degree AV blockb |
Lidocaine (IV) |
50 mg IV over 2 min; can be repeated every 5 min up to total of 200 mg followed by infusion of 1-4 mg/min; dose should be tapered off |
– |
Hypersensitivity to local anesthetic drugs |
Metoprolol (IV, PO) |
5 mg IV every 5-10 min up to total of 15 mg |
50-200 mg/d |
Second-degree or third-degree AV block,b symptomatic bradycardia, symptomatic hypotension, sick sinus syndrome, decompensated HF, asthma |
Procainamide (IV) |
Loading dose: 100-200 mg/dose or 15-18 mg/kg; do not exceed 50 mg/min; can be repeated every 5 min if required; do not exceed 1 g Maintenance dose: 1-4 mg/min IV infusion |
– |
Sinus node dysfunction, second-degree or third-degree AV blockb, prolonged QT, drug hypersensitivity |
Propranolol (IV, PO) |
1-5 mg IV (in selected cases 10 mg); administer 1 mg over 1 min |
20-40 mg every 8 h |
Second-degree or third-degree AV block,b symptomatic bradycardia, symptomatic hypotension, sick sinus syndrome, decompensated HF, asthma |
Propafenone (IV, PO) |
1-2 mg/kg IV over 5 min PO: 600 mg (“pill in the pocket” for AF) |
150-300 mg every 8-12 h |
Structural heart disease (in particular HF), CAD, sinus node dysfunction, second-degree or third-degree AV blockb |
Verapamil (IV, PO) |
5-10 mg IV over 1-2 min |
120-360 mg/d |
HF, second-degree or third-degree AV blockb |
a Monitor electrocardiography and blood pressure. b In patients without an implanted pacemaker. | |||
AF, atrial fibrillation; AFL, atrial flutter; AV, atrioventricular; bid, 2 times a day; CAD, coronary artery disease; HF, heart failure; IV, intravenous; LV, left ventricle; PO, oral; tid, 3 times a day; VT, ventricular tachycardia. |